EDN1 and COVID-19: In addition, ET‐1 could have an important role in COVID‐19 thromboembolic events since higher plasma levels of ET‐1 were found in patients with disseminated intravascular coagulation and are considered a predictive factor of poor outcome (Asakura et al., 1992).